L'impiego della tossina botulinica tipo A nelle sindromi dolorose miofasciali
Matteo Della Porta(University of Milan), Maurizio Fornari(IRCCS Humanitas Research Hospital), Mario Loiero, Mônica Antar Gamba(Universidade Federal de São Paulo), G. Luccarelli
Unknown
January 1, 1999
Cited by 4
Related Papers
Magnesium in Obesity, Metabolic Syndrome, and Type 2 Diabetes
|Nutrients|2021|236
Treatment of sialorrhoea with ultrasound guided botulinum toxin type A injection in patients with neurological disorders
|Journal of Neurology Neurosurgery & Psychiatry|2001|157
Going to the roots of reduced magnesium dietary intake: A tradeoff between climate changes and sources
|Heliyon|2020|74
Anti-inflammatory effects of diet and caloric restriction in metabolic syndrome
|Journal of Endocrinological Investigation|2021|65